Aging Clinical Trial
— CPEPolderOfficial title:
Cardiopulmonary Response to Conical Positive Expiratory Breathing During Exercise in Older People.
Verified date | August 2017 |
Source | Khon Kaen University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Aim of this study is to compare cardiopulmonary response to conical-PEP breathing during exercise in older people.
Status | Active, not recruiting |
Enrollment | 12 |
Est. completion date | December 2017 |
Est. primary completion date | November 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Elder age between 60 to 80 years old with normal spirometry Exclusion Criteria: - They are diagnose with cardiovascular disease and, i.e. valvular heart disease, coronary heart disease, congenital heart disease, myocardial heart disease, uncontrolled hypertension, hyperlipidemia; or, present abnormal sign of heart problems previous month, such as chest pain, arrhythmia, abnormal ECG. - They are impair balance from neuromuscular, musculoskeletal, or vestibular problem affecting cycling and walking. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Khon Kaen University | Thailand Research Fund |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of Inspiratory capacity (IC) | Participants will be measured IC with slow vital capacity maneuver following American thoracic Society (ATS) and European Respiratory Society (ERS) statement for spirometry (2005). | resting, immediate post exercise test and end recovery period of 10 minutes | |
Secondary | Change of Slow vital capacity (SVC) | Participants will be measured SVC with slow vital capacity maneuver following American thoracic Society (ATS) and European Respiratory Society (ERS) statement for spirometry (2005). | resting, immediate post exercise test and end recovery period of 10 minutes | |
Secondary | Change of respiratory rate (RR) | The RR will be measured by a flow transducer of BioPAC system MP 36. The RR will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of hear rate (HR) | Participants will be continuously recorded EKG by the BioPAC system MP 36 The HR will be collected from EKG. Moreover, real time EKG with HR will be measured by bedside monitor for termination criteria . | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of inspiratory time (Ti) | The Ti will measure by a flow transducer of BioPAC system MP 36. The Ti will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of expiratory time (Te) | The Te will measure by a flow transducer of BioPAC system MP 36. The Te will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of inspiratory and expiratory time ratio (IE ratio) | The IE ratio will measure by a flow transducer of BioPAC system MP 36. The IE ratio will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of tidal volume (VT) | The VT will measure by a flow transducer of BioPAC system MP 36. The VT will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of expiratory minute ventilation (VE) | The VE will calculate from RR and VT and will present at resting, during exercise every minute, end exercise and every minute in recovery period for 10 minute | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of mean expiratory flow rate (MEF) | The MEF will measure by a flow transducer of BioPAC system MP 36. The MEF will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of peak expiratory flow rate (PEF) | The PEF will measure by a flow transducer of BioPAC system MP 36. The PEF will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of mean expiratory pressure (MEP) | The MEP will measure by a pressure transducer of BioPAC system MP 36. The MEP will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of peak expiratory pressure (PEP) | The PEP will measure by a pressure transducer of BioPAC system MP 36. The PEP will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of pule oxygen saturation (SpO2) | Participants will be continuously measured SpO2 throughout the test. Researcher will collect SpO2 at resting, every minute during exercise, end exercise test and every minute of recovery period for 10 minutes. | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of end tidal carbon dioxide pressure (PetCO2) | Participants will be continuously measured PetCO2 throughout the test. Researcher will collect PetCO2 at resting, every minute during exercise, end exercise test and every minute of recovery period for 10 minutes. | Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of rating perceive of breathlessness (RPB) | Participant will rate RPB using a modified Borg dyspnea 10 scale at resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes. | resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes | |
Secondary | Change of leg fatigue | Participant will rate their leg fatigue using a visual analog scale at resting, end exercise test and end recovery period for 10 minutes. | resting, , end exercise test and end recovery period | |
Secondary | Change of systolic blood pressure (SBP) | The SBP will be measured by a bedside monitor at resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes. | resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes | |
Secondary | Change of diastolic blood pressure (DBP) | The SBP will be measured by a bedside monitor at resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes. | resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes | |
Secondary | Change of mean arterial pressure (MAP) | The MAP will be measured by a bedside monitor at resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes. | resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |